Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Biological Control Market

ID: MRFR/Agri/29793-HCR
128 Pages
Snehal Singh
Last Updated: April 06, 2026

Biological Control Market Size, Share, Industry Trend & Analysis Research Report By Control Mechanism (Microbial Control, Natural Predators, Parasitoids, Pathogens), By Application (Agricultural Practices, Horticulture, Forestry, Aquaculture), By Formulation Type (Liquid Formulations, Granular Formulations, Powder Formulations), By Crop Type (Row Crops, Fruit & Vegetable Crops, Cereals & Pulses, Turf and Ornamental Plants), By End-user Sector (Farming Sector, Research & Development Organizations, Government Bodies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Biological Control Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Control Mechanism (USD Billion)
  49.     4.1.1 Microbial Control
  50.     4.1.2 Natural Predators
  51.     4.1.3 Parasitoids
  52.     4.1.4 Pathogens
  53.   4.2 Healthcare, BY Application (USD Billion)
  54.     4.2.1 Agricultural Practices
  55.     4.2.2 Horticulture
  56.     4.2.3 Forestry
  57.     4.2.4 Aquaculture
  58.   4.3 Healthcare, BY Formulation Type (USD Billion)
  59.     4.3.1 Liquid Formulations
  60.     4.3.2 Granular Formulations
  61.     4.3.3 Powder Formulations
  62.   4.4 Healthcare, BY Crop Type (USD Billion)
  63.     4.4.1 Row Crops
  64.     4.4.2 Fruit Vegetable Crops
  65.     4.4.3 Cereals Pulses
  66.     4.4.4 Turf and Ornamental Plants
  67.   4.5 Healthcare, BY End-user Sector (USD Billion)
  68.     4.5.1 Farming Sector
  69.     4.5.2 Research Development Organizations
  70.     4.5.3 Government Bodies
  71.   4.6 Healthcare, BY Region (USD Billion)
  72.     4.6.1 North America
  73.       4.6.1.1 US
  74.       4.6.1.2 Canada
  75.     4.6.2 Europe
  76.       4.6.2.1 Germany
  77.       4.6.2.2 UK
  78.       4.6.2.3 France
  79.       4.6.2.4 Russia
  80.       4.6.2.5 Italy
  81.       4.6.2.6 Spain
  82.       4.6.2.7 Rest of Europe
  83.     4.6.3 APAC
  84.       4.6.3.1 China
  85.       4.6.3.2 India
  86.       4.6.3.3 Japan
  87.       4.6.3.4 South Korea
  88.       4.6.3.5 Malaysia
  89.       4.6.3.6 Thailand
  90.       4.6.3.7 Indonesia
  91.       4.6.3.8 Rest of APAC
  92.     4.6.4 South America
  93.       4.6.4.1 Brazil
  94.       4.6.4.2 Mexico
  95.       4.6.4.3 Argentina
  96.       4.6.4.4 Rest of South America
  97.     4.6.5 MEA
  98.       4.6.5.1 GCC Countries
  99.       4.6.5.2 South Africa
  100.       4.6.5.3 Rest of MEA
  101. 5 SECTION V: COMPETITIVE ANALYSIS
  102.   5.1 Competitive Landscape
  103.     5.1.1 Overview
  104.     5.1.2 Competitive Analysis
  105.     5.1.3 Market share Analysis
  106.     5.1.4 Major Growth Strategy in the Healthcare
  107.     5.1.5 Competitive Benchmarking
  108.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  109.     5.1.7 Key developments and growth strategies
  110.       5.1.7.1 New Product Launch/Service Deployment
  111.       5.1.7.2 Merger & Acquisitions
  112.       5.1.7.3 Joint Ventures
  113.     5.1.8 Major Players Financial Matrix
  114.       5.1.8.1 Sales and Operating Income
  115.       5.1.8.2 Major Players R&D Expenditure. 2023
  116.   5.2 Company Profiles
  117.     5.2.1 BASF SE (DE)
  118.       5.2.1.1 Financial Overview
  119.       5.2.1.2 Products Offered
  120.       5.2.1.3 Key Developments
  121.       5.2.1.4 SWOT Analysis
  122.       5.2.1.5 Key Strategies
  123.     5.2.2 Syngenta AG (CH)
  124.       5.2.2.1 Financial Overview
  125.       5.2.2.2 Products Offered
  126.       5.2.2.3 Key Developments
  127.       5.2.2.4 SWOT Analysis
  128.       5.2.2.5 Key Strategies
  129.     5.2.3 Bayer AG (DE)
  130.       5.2.3.1 Financial Overview
  131.       5.2.3.2 Products Offered
  132.       5.2.3.3 Key Developments
  133.       5.2.3.4 SWOT Analysis
  134.       5.2.3.5 Key Strategies
  135.     5.2.4 FMC Corporation (US)
  136.       5.2.4.1 Financial Overview
  137.       5.2.4.2 Products Offered
  138.       5.2.4.3 Key Developments
  139.       5.2.4.4 SWOT Analysis
  140.       5.2.4.5 Key Strategies
  141.     5.2.5 Valent BioSciences LLC (US)
  142.       5.2.5.1 Financial Overview
  143.       5.2.5.2 Products Offered
  144.       5.2.5.3 Key Developments
  145.       5.2.5.4 SWOT Analysis
  146.       5.2.5.5 Key Strategies
  147.     5.2.6 Certis USA LLC (US)
  148.       5.2.6.1 Financial Overview
  149.       5.2.6.2 Products Offered
  150.       5.2.6.3 Key Developments
  151.       5.2.6.4 SWOT Analysis
  152.       5.2.6.5 Key Strategies
  153.     5.2.7 Koppert Biological Systems (NL)
  154.       5.2.7.1 Financial Overview
  155.       5.2.7.2 Products Offered
  156.       5.2.7.3 Key Developments
  157.       5.2.7.4 SWOT Analysis
  158.       5.2.7.5 Key Strategies
  159.     5.2.8 Biobest Group NV (BE)
  160.       5.2.8.1 Financial Overview
  161.       5.2.8.2 Products Offered
  162.       5.2.8.3 Key Developments
  163.       5.2.8.4 SWOT Analysis
  164.       5.2.8.5 Key Strategies
  165.     5.2.9 AgBiTech Pty Ltd (AU)
  166.       5.2.9.1 Financial Overview
  167.       5.2.9.2 Products Offered
  168.       5.2.9.3 Key Developments
  169.       5.2.9.4 SWOT Analysis
  170.       5.2.9.5 Key Strategies
  171.   5.3 Appendix
  172.     5.3.1 References
  173.     5.3.2 Related Reports
  174. 6 LIST OF FIGURES
  175.   6.1 MARKET SYNOPSIS
  176.   6.2 NORTH AMERICA MARKET ANALYSIS
  177.   6.3 US MARKET ANALYSIS BY CONTROL MECHANISM
  178.   6.4 US MARKET ANALYSIS BY APPLICATION
  179.   6.5 US MARKET ANALYSIS BY FORMULATION TYPE
  180.   6.6 US MARKET ANALYSIS BY CROP TYPE
  181.   6.7 US MARKET ANALYSIS BY END-USER SECTOR
  182.   6.8 CANADA MARKET ANALYSIS BY CONTROL MECHANISM
  183.   6.9 CANADA MARKET ANALYSIS BY APPLICATION
  184.   6.10 CANADA MARKET ANALYSIS BY FORMULATION TYPE
  185.   6.11 CANADA MARKET ANALYSIS BY CROP TYPE
  186.   6.12 CANADA MARKET ANALYSIS BY END-USER SECTOR
  187.   6.13 EUROPE MARKET ANALYSIS
  188.   6.14 GERMANY MARKET ANALYSIS BY CONTROL MECHANISM
  189.   6.15 GERMANY MARKET ANALYSIS BY APPLICATION
  190.   6.16 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
  191.   6.17 GERMANY MARKET ANALYSIS BY CROP TYPE
  192.   6.18 GERMANY MARKET ANALYSIS BY END-USER SECTOR
  193.   6.19 UK MARKET ANALYSIS BY CONTROL MECHANISM
  194.   6.20 UK MARKET ANALYSIS BY APPLICATION
  195.   6.21 UK MARKET ANALYSIS BY FORMULATION TYPE
  196.   6.22 UK MARKET ANALYSIS BY CROP TYPE
  197.   6.23 UK MARKET ANALYSIS BY END-USER SECTOR
  198.   6.24 FRANCE MARKET ANALYSIS BY CONTROL MECHANISM
  199.   6.25 FRANCE MARKET ANALYSIS BY APPLICATION
  200.   6.26 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
  201.   6.27 FRANCE MARKET ANALYSIS BY CROP TYPE
  202.   6.28 FRANCE MARKET ANALYSIS BY END-USER SECTOR
  203.   6.29 RUSSIA MARKET ANALYSIS BY CONTROL MECHANISM
  204.   6.30 RUSSIA MARKET ANALYSIS BY APPLICATION
  205.   6.31 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
  206.   6.32 RUSSIA MARKET ANALYSIS BY CROP TYPE
  207.   6.33 RUSSIA MARKET ANALYSIS BY END-USER SECTOR
  208.   6.34 ITALY MARKET ANALYSIS BY CONTROL MECHANISM
  209.   6.35 ITALY MARKET ANALYSIS BY APPLICATION
  210.   6.36 ITALY MARKET ANALYSIS BY FORMULATION TYPE
  211.   6.37 ITALY MARKET ANALYSIS BY CROP TYPE
  212.   6.38 ITALY MARKET ANALYSIS BY END-USER SECTOR
  213.   6.39 SPAIN MARKET ANALYSIS BY CONTROL MECHANISM
  214.   6.40 SPAIN MARKET ANALYSIS BY APPLICATION
  215.   6.41 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
  216.   6.42 SPAIN MARKET ANALYSIS BY CROP TYPE
  217.   6.43 SPAIN MARKET ANALYSIS BY END-USER SECTOR
  218.   6.44 REST OF EUROPE MARKET ANALYSIS BY CONTROL MECHANISM
  219.   6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  220.   6.46 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
  221.   6.47 REST OF EUROPE MARKET ANALYSIS BY CROP TYPE
  222.   6.48 REST OF EUROPE MARKET ANALYSIS BY END-USER SECTOR
  223.   6.49 APAC MARKET ANALYSIS
  224.   6.50 CHINA MARKET ANALYSIS BY CONTROL MECHANISM
  225.   6.51 CHINA MARKET ANALYSIS BY APPLICATION
  226.   6.52 CHINA MARKET ANALYSIS BY FORMULATION TYPE
  227.   6.53 CHINA MARKET ANALYSIS BY CROP TYPE
  228.   6.54 CHINA MARKET ANALYSIS BY END-USER SECTOR
  229.   6.55 INDIA MARKET ANALYSIS BY CONTROL MECHANISM
  230.   6.56 INDIA MARKET ANALYSIS BY APPLICATION
  231.   6.57 INDIA MARKET ANALYSIS BY FORMULATION TYPE
  232.   6.58 INDIA MARKET ANALYSIS BY CROP TYPE
  233.   6.59 INDIA MARKET ANALYSIS BY END-USER SECTOR
  234.   6.60 JAPAN MARKET ANALYSIS BY CONTROL MECHANISM
  235.   6.61 JAPAN MARKET ANALYSIS BY APPLICATION
  236.   6.62 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
  237.   6.63 JAPAN MARKET ANALYSIS BY CROP TYPE
  238.   6.64 JAPAN MARKET ANALYSIS BY END-USER SECTOR
  239.   6.65 SOUTH KOREA MARKET ANALYSIS BY CONTROL MECHANISM
  240.   6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  241.   6.67 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
  242.   6.68 SOUTH KOREA MARKET ANALYSIS BY CROP TYPE
  243.   6.69 SOUTH KOREA MARKET ANALYSIS BY END-USER SECTOR
  244.   6.70 MALAYSIA MARKET ANALYSIS BY CONTROL MECHANISM
  245.   6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION
  246.   6.72 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
  247.   6.73 MALAYSIA MARKET ANALYSIS BY CROP TYPE
  248.   6.74 MALAYSIA MARKET ANALYSIS BY END-USER SECTOR
  249.   6.75 THAILAND MARKET ANALYSIS BY CONTROL MECHANISM
  250.   6.76 THAILAND MARKET ANALYSIS BY APPLICATION
  251.   6.77 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
  252.   6.78 THAILAND MARKET ANALYSIS BY CROP TYPE
  253.   6.79 THAILAND MARKET ANALYSIS BY END-USER SECTOR
  254.   6.80 INDONESIA MARKET ANALYSIS BY CONTROL MECHANISM
  255.   6.81 INDONESIA MARKET ANALYSIS BY APPLICATION
  256.   6.82 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
  257.   6.83 INDONESIA MARKET ANALYSIS BY CROP TYPE
  258.   6.84 INDONESIA MARKET ANALYSIS BY END-USER SECTOR
  259.   6.85 REST OF APAC MARKET ANALYSIS BY CONTROL MECHANISM
  260.   6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION
  261.   6.87 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
  262.   6.88 REST OF APAC MARKET ANALYSIS BY CROP TYPE
  263.   6.89 REST OF APAC MARKET ANALYSIS BY END-USER SECTOR
  264.   6.90 SOUTH AMERICA MARKET ANALYSIS
  265.   6.91 BRAZIL MARKET ANALYSIS BY CONTROL MECHANISM
  266.   6.92 BRAZIL MARKET ANALYSIS BY APPLICATION
  267.   6.93 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
  268.   6.94 BRAZIL MARKET ANALYSIS BY CROP TYPE
  269.   6.95 BRAZIL MARKET ANALYSIS BY END-USER SECTOR
  270.   6.96 MEXICO MARKET ANALYSIS BY CONTROL MECHANISM
  271.   6.97 MEXICO MARKET ANALYSIS BY APPLICATION
  272.   6.98 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
  273.   6.99 MEXICO MARKET ANALYSIS BY CROP TYPE
  274.   6.100 MEXICO MARKET ANALYSIS BY END-USER SECTOR
  275.   6.101 ARGENTINA MARKET ANALYSIS BY CONTROL MECHANISM
  276.   6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION
  277.   6.103 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
  278.   6.104 ARGENTINA MARKET ANALYSIS BY CROP TYPE
  279.   6.105 ARGENTINA MARKET ANALYSIS BY END-USER SECTOR
  280.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY CONTROL MECHANISM
  281.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  282.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
  283.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY CROP TYPE
  284.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER SECTOR
  285.   6.111 MEA MARKET ANALYSIS
  286.   6.112 GCC COUNTRIES MARKET ANALYSIS BY CONTROL MECHANISM
  287.   6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  288.   6.114 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
  289.   6.115 GCC COUNTRIES MARKET ANALYSIS BY CROP TYPE
  290.   6.116 GCC COUNTRIES MARKET ANALYSIS BY END-USER SECTOR
  291.   6.117 SOUTH AFRICA MARKET ANALYSIS BY CONTROL MECHANISM
  292.   6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  293.   6.119 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
  294.   6.120 SOUTH AFRICA MARKET ANALYSIS BY CROP TYPE
  295.   6.121 SOUTH AFRICA MARKET ANALYSIS BY END-USER SECTOR
  296.   6.122 REST OF MEA MARKET ANALYSIS BY CONTROL MECHANISM
  297.   6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION
  298.   6.124 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
  299.   6.125 REST OF MEA MARKET ANALYSIS BY CROP TYPE
  300.   6.126 REST OF MEA MARKET ANALYSIS BY END-USER SECTOR
  301.   6.127 KEY BUYING CRITERIA OF HEALTHCARE
  302.   6.128 RESEARCH PROCESS OF MRFR
  303.   6.129 DRO ANALYSIS OF HEALTHCARE
  304.   6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  305.   6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  306.   6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
  307.   6.133 HEALTHCARE, BY CONTROL MECHANISM, 2024 (% SHARE)
  308.   6.134 HEALTHCARE, BY CONTROL MECHANISM, 2024 TO 2035 (USD Billion)
  309.   6.135 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  310.   6.136 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  311.   6.137 HEALTHCARE, BY FORMULATION TYPE, 2024 (% SHARE)
  312.   6.138 HEALTHCARE, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
  313.   6.139 HEALTHCARE, BY CROP TYPE, 2024 (% SHARE)
  314.   6.140 HEALTHCARE, BY CROP TYPE, 2024 TO 2035 (USD Billion)
  315.   6.141 HEALTHCARE, BY END-USER SECTOR, 2024 (% SHARE)
  316.   6.142 HEALTHCARE, BY END-USER SECTOR, 2024 TO 2035 (USD Billion)
  317.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  318. 7 LIST OF TABLES
  319.   7.1 LIST OF ASSUMPTIONS
  320.     7.1.1
  321.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  322.     7.2.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  323.     7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  324.     7.2.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  325.     7.2.4 BY CROP TYPE, 2025-2035 (USD Billion)
  326.     7.2.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  327.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  328.     7.3.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  329.     7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  330.     7.3.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  331.     7.3.4 BY CROP TYPE, 2025-2035 (USD Billion)
  332.     7.3.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  333.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  334.     7.4.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  335.     7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  336.     7.4.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  337.     7.4.4 BY CROP TYPE, 2025-2035 (USD Billion)
  338.     7.4.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  339.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  340.     7.5.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  341.     7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  342.     7.5.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  343.     7.5.4 BY CROP TYPE, 2025-2035 (USD Billion)
  344.     7.5.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  345.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  346.     7.6.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  347.     7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  348.     7.6.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  349.     7.6.4 BY CROP TYPE, 2025-2035 (USD Billion)
  350.     7.6.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  351.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  352.     7.7.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  353.     7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  354.     7.7.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  355.     7.7.4 BY CROP TYPE, 2025-2035 (USD Billion)
  356.     7.7.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  357.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  358.     7.8.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  359.     7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  360.     7.8.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  361.     7.8.4 BY CROP TYPE, 2025-2035 (USD Billion)
  362.     7.8.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  363.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  364.     7.9.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  365.     7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  366.     7.9.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  367.     7.9.4 BY CROP TYPE, 2025-2035 (USD Billion)
  368.     7.9.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  369.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  370.     7.10.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  371.     7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  372.     7.10.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  373.     7.10.4 BY CROP TYPE, 2025-2035 (USD Billion)
  374.     7.10.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  375.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  376.     7.11.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  377.     7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  378.     7.11.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  379.     7.11.4 BY CROP TYPE, 2025-2035 (USD Billion)
  380.     7.11.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  381.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  382.     7.12.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  383.     7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  384.     7.12.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  385.     7.12.4 BY CROP TYPE, 2025-2035 (USD Billion)
  386.     7.12.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  387.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  388.     7.13.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  389.     7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  390.     7.13.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  391.     7.13.4 BY CROP TYPE, 2025-2035 (USD Billion)
  392.     7.13.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  393.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  394.     7.14.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  395.     7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  396.     7.14.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  397.     7.14.4 BY CROP TYPE, 2025-2035 (USD Billion)
  398.     7.14.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  399.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  400.     7.15.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  401.     7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  402.     7.15.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  403.     7.15.4 BY CROP TYPE, 2025-2035 (USD Billion)
  404.     7.15.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  405.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  406.     7.16.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  407.     7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  408.     7.16.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  409.     7.16.4 BY CROP TYPE, 2025-2035 (USD Billion)
  410.     7.16.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  411.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  412.     7.17.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  413.     7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  414.     7.17.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  415.     7.17.4 BY CROP TYPE, 2025-2035 (USD Billion)
  416.     7.17.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  417.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  418.     7.18.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  419.     7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  420.     7.18.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  421.     7.18.4 BY CROP TYPE, 2025-2035 (USD Billion)
  422.     7.18.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  423.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  424.     7.19.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  425.     7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  426.     7.19.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  427.     7.19.4 BY CROP TYPE, 2025-2035 (USD Billion)
  428.     7.19.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  429.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  430.     7.20.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  431.     7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  432.     7.20.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  433.     7.20.4 BY CROP TYPE, 2025-2035 (USD Billion)
  434.     7.20.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  435.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  436.     7.21.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  437.     7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  438.     7.21.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  439.     7.21.4 BY CROP TYPE, 2025-2035 (USD Billion)
  440.     7.21.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  441.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  442.     7.22.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  443.     7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  444.     7.22.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  445.     7.22.4 BY CROP TYPE, 2025-2035 (USD Billion)
  446.     7.22.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  447.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  448.     7.23.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  449.     7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  450.     7.23.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  451.     7.23.4 BY CROP TYPE, 2025-2035 (USD Billion)
  452.     7.23.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  453.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  454.     7.24.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  455.     7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  456.     7.24.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  457.     7.24.4 BY CROP TYPE, 2025-2035 (USD Billion)
  458.     7.24.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  459.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  460.     7.25.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  461.     7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  462.     7.25.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  463.     7.25.4 BY CROP TYPE, 2025-2035 (USD Billion)
  464.     7.25.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  465.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  466.     7.26.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  467.     7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  468.     7.26.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  469.     7.26.4 BY CROP TYPE, 2025-2035 (USD Billion)
  470.     7.26.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  471.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  472.     7.27.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  473.     7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  474.     7.27.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  475.     7.27.4 BY CROP TYPE, 2025-2035 (USD Billion)
  476.     7.27.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  477.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  478.     7.28.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  479.     7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  480.     7.28.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  481.     7.28.4 BY CROP TYPE, 2025-2035 (USD Billion)
  482.     7.28.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  483.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  484.     7.29.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  485.     7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  486.     7.29.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  487.     7.29.4 BY CROP TYPE, 2025-2035 (USD Billion)
  488.     7.29.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  489.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  490.     7.30.1 BY CONTROL MECHANISM, 2025-2035 (USD Billion)
  491.     7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  492.     7.30.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  493.     7.30.4 BY CROP TYPE, 2025-2035 (USD Billion)
  494.     7.30.5 BY END-USER SECTOR, 2025-2035 (USD Billion)
  495.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  496.     7.31.1
  497.   7.32 ACQUISITION/PARTNERSHIP
  498.     7.32.1

Healthcare Market Segmentation

Healthcare By Control Mechanism (USD Billion, 2025-2035)

  • Microbial Control
  • Natural Predators
  • Parasitoids
  • Pathogens

Healthcare By Application (USD Billion, 2025-2035)

  • Agricultural Practices
  • Horticulture
  • Forestry
  • Aquaculture

Healthcare By Formulation Type (USD Billion, 2025-2035)

  • Liquid Formulations
  • Granular Formulations
  • Powder Formulations

Healthcare By Crop Type (USD Billion, 2025-2035)

  • Row Crops
  • Fruit Vegetable Crops
  • Cereals Pulses
  • Turf and Ornamental Plants

Healthcare By End-user Sector (USD Billion, 2025-2035)

  • Farming Sector
  • Research Development Organizations
  • Government Bodies

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions